Abstract
Background
The pro-inflammatory cytokine IL-1 plays an important role in severe COVID-19. A change in IL-1 production may be associated with a mutation in the IL1Β gene. Our study analyzed the impact of the IL1Β gene variants (rs1143634) on disease progression in patients with severe COVID-19 pneumonia, taking into account treatment strategies.
Methods and results
The study enrolled 117 patients with severe COVID-19 pneumonia. The IL1Β gene variants were identified using the polymerase chain reaction-restriction fragment length polymorphism method. In the group of patients, the following genotype frequencies were found based on the investigated rs1143634 variant of the IL1Β gene: CC–65.8%, CT–28.2%, and TT–6.0%. Our results showed that the group of patients with the T allele of the IL1Β gene had higher leukocyte counts (p = 0.040) and more pronounced lymphopenia (p = 0.007). It was determined that patients carrying the T allele stayed on ventilators significantly longer (p = 0.049) and required longer treatment with corticosteroids (p = 0.045).
Conclusion
Identifying variants of the IL1Β gene can be used as a predictive tool for assessing the severity of COVID-19 pneumonia and tailoring personalized treatment strategies. Further research with a larger patient cohort is required to validate these findings.
Similar content being viewed by others
References
Worldometers (2023). https://www.worldometers.info/coronavirus/ Accessed 19 Mar 2024.
HO, World Health Organization. https://www.who.int/news-room/speeches/item/who-director-general-s-opening-remarks-at-the-media-briefing---5-may-2023 /Accessed 19 Mar 2024
Vatansever HS, Becer E (2020) Relationship between IL-6 and COVID-19: to be considered during treatment. Future Virol. https://doi.org/10.2217/fvl-2020-0168
Tanaka T, Narazaki M, Kishimoto T (2014) IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol 6(10):a016295. https://doi.org/10.1101/cshperspect.a016295
Gallenga CE, Pandolfi F, Al C et al (2019) Interleukin-1 family cytokines and mast cells: activation and inhibition. J Biol Regul Homeost Agents 33(1):1–6
Italiani P, Puxeddu I, Napoletano S et al (2018) Circulating levels of IL-1 family cytokines and receptors in Alzheimer’s disease: new markers of disease progression? J Neuroinflammation 15(1):342. https://doi.org/10.1186/s12974-018-1376-1
Rodrigues TS, de Sá KSG, Ishimoto AY et al (2021) Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients. J Exp Med 218(3):e20201707. https://doi.org/10.1084/jem.20201707
Kaidashev I, Shlykova O, Izmailova O (2021) Host gene variability and SARS-CoV-2 infection: A review article. Heliyon 7(8):e07863. https://doi.org/10.1016/j.heliyon.2021.e07863
Fang Y, Xie H, Lin Z (2018) Association between IL-1β + 3954C/T polymorphism and myocardial infarction risk: A meta-analysis. Medicine (Baltimore) 97(30):e11645. https://doi.org/10.1097/MD.0000000000011645
MOZ UA, (2021) Algorithm for providing hospital medical care in case of COVID-19. https://moz.gov.ua/uploads/7/35121-algoritm_stac_covid_19.pdf / Accessed 19 Mar 2024
Kolov G, Grytsay M, Tsokalo V et al (2021) Variants of IL1 (C3954T, RS1143634), PON1 (C108T, RS705379) genes as prognostic markers of osteomyelitis risk and its complications. Georgian Med News 318:93–98
1000 Genomes Project Phase 3, (2023). http://www.ensembl.org/ Accessed 19 March 2024
Sefik E, Qu R, Junqueira C et al (2022) Inflammasome activation in infected macrophages drives COVID-19 pathology. Nature 606(7914):585–593. https://doi.org/10.1038/s41586-022-04802-1
Moore JB, June CH (2020) Cytokine release syndrome in severe COVID-19. Science 368(6490):473–474. https://doi.org/10.1126/science.abb8925
Coperchini F, Chiovato L, Croce L et al (2020) The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system. Cytokine Growth Factor Rev 53:25–32. https://doi.org/10.1016/j.cytogfr.2020.05.003
Wang J, Jiang M, Chen X et al (2020) Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts. J Leukoc Biol 108(1):17–41. https://doi.org/10.1002/JLB.3COVR0520-272R
She YX, Yu QY, Tang XX (2021) Role of interleukins in the pathogenesis of pulmonary fibrosis. Cell Death Discov 7(1):52. https://doi.org/10.1038/s41420-021-00437-9
Root-Bernstein R (2021) Innate receptor activation patterns involving TLR and NLR synergisms in COVID-19, ALI/ARDS and sepsis cytokine storms: a review and model making novel predictions and therapeutic suggestions. Int J Mol Sc 22(4):2108. https://doi.org/10.3390/ijms22042108
Qin C, Zhou L, Hu Z et al (2020) Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in wuhan. China Clin Infect Dis 71(15):762–768. https://doi.org/10.1093/cid/ciaa248
Tan L, Wang Q, Zhang D et al (2020) Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study [published correction appears in Signal Transduct Target Ther. 2020 Apr 29;5(1):61]. Signal Transduct Target Ther 5(1):33. https://doi.org/10.1038/s41392-020-0148-4
Cortés-Vieyra R, Gutiérrez-Castellanos S, Álvarez-Aguilar C et al (2021) Behavior of eosinophil counts in recovered and deceased COVID-19 patients over the course of the disease. Viruses 13(9):1675. https://doi.org/10.3390/v13091675
Tong X, Cheng A, Yuan X et al (2021) Characteristics of peripheral white blood cells in COVID-19 patients revealed by a retrospective cohort study. BMC Infect Dis 21(1):1236. https://doi.org/10.1186/s12879-021-06899-7
Iannaccone G, Scacciavillani R, Del Buono MG et al (2020) Weathering the cytokine storm in COVID-19: therapeutic implications. Cardiorenal Med 10(5):277–287. https://doi.org/10.1159/000509483
Potere N, Del Buono MG, Caricchio R et al (2022) Interleukin-1 and the NLRP3 inflammasome in COVID-19: pathogenetic and therapeutic implications. EBioMedicine 85:104299. https://doi.org/10.1016/j.ebiom.2022.104299
Caricchio R, Gallucci M, Dass C et al (2021) Preliminary predictive criteria for COVID-19 cytokine storm. Ann Rheum Dis 80(1):88–95. https://doi.org/10.1136/annrheumdis-2020-218323
van de Veerdonk FL, Netea MG (2020) Blocking IL-1 to prevent respiratory failure in COVID-19. Crit Care 2:445. https://doi.org/10.1186/s13054-020-03166-0
Neira-Goulart M, de Sá NBR, Ribeiro-Alves M et al (2023) Inflammasome genes polymorphisms are associated with progression to mechanical ventilation and death in a cohort of hospitalized COVID-19 patients in a reference hospital in Rio de Janeiro. Brazil Gene 865:147325. https://doi.org/10.1016/j.gene.2023.147325
Salihefendić L, Čeko I, Bešić L et al (2023) Identification of human genetic variants modulating the course of COVID-19 infection with importance in other viral infections. Front Genet 14:1240245. https://doi.org/10.3389/fgene.2023.1240245
Borthwick LA (2016) The IL-1 cytokine family and its role in inflammation and fibrosis in the lung. Semin Immunopathol 38(4):517–534. https://doi.org/10.1007/s00281-016-0559-z
Ronchetti S, Migliorati G, Bruscoli S et al (2018) Defining the role of glucocorticoids in inflammation. Clin Sci (Lond) 132(14):1529–1543. https://doi.org/10.1042/CS20171505
RECOVERY Collaborative Group, Horby P, Lim WS et al (2021) Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 384(8):693–704. https://doi.org/10.1056/NEJMoa2021436
Sarkar S, Khanna P, Soni KD (2021) Are the steroids a blanket solution for COVID-19? a systematic review and meta-analysis. J Med Virol 93(3):1538–1547. https://doi.org/10.1002/jmv.26483
Lee SW, Tsou AP, Chan H et al (1988) Glucocorticoids selectively inhibit the transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA. Proc Natl Acad Sci USA 85(4):1204–1208. https://doi.org/10.1073/pnas.85.4.1204
Zhang G, Zhang L, Duff GW (1997) A negative regulatory region containing a glucocorticosteroid response element (nGRE) in the human interleukin-1beta gene. DNA Cell Biol 16(2):145–152. https://doi.org/10.1089/dna.1997.16.145
Alexaki VI, Henneicke H (2021) The role of glucocorticoids in the management of COVID-19. Horm Metab Res 53(1):9–15. https://doi.org/10.1055/a-1300-2550
Yu Z, Han S, Cao X et al (2012) Genetic polymorphisms in adipokine genes and the risk of obesity: a systematic review and meta-analysis. Obesity (Silver Spring) 20(2):396–406. https://doi.org/10.1038/oby.2011.148
Funding
This study did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Contributions
All authors contributed to manuscript preparation. Conception, design, and methodology: VP, ZR, and NG. Data collection: VP, HS, LZ. Molecular analysis: OP, VV, OI. Data Curation: YC. Manuscript drafting: YC, LF. Statistical analysis: LF. Critical revision and editing: VP, ZR, NG. AA. All authors have read and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors have no relevant financial or non-financial interests to disclose.
Ethical approval
This study was conducted in accordance with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Poltava State Medical University (minutes No.188 as of November 25, 2020). Informed consent was obtained from all individuals participating in this study.
Data availability
No data associated with the manuscript.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Pokhylko, V., Cherniavska, Y., Fishchuk, L. et al. Association of the C3953T (rs1143634) variant of the interleukin 1 beta gene with the features of a complicated course of COVID-19-associated pneumonia. Mol Biol Rep 51, 630 (2024). https://doi.org/10.1007/s11033-024-09569-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11033-024-09569-4